---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-26-021658"
form_type: "8-K"
ticker: "CURX"
cik: "0002025942"
company_name: "Curanex Pharmaceuticals Inc"
filed_at: "2026-05-07T23:59:59+00:00"
generated_at: "2026-05-14T22:06:01.163337+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Nasdaq grants CURX additional 180 days until Nov 2, 2026 to meet $1 bid price

## Summary
- Received Nasdaq notice on Nov 5, 2025 for bid price below $1.00; initial 180-day period ended May 4, 2026.
- Nasdaq granted second 180-day compliance period through Nov 2, 2026, based on meeting other listing requirements.
- Company may implement a reverse stock split to cure the deficiency.
- If bid price stays at $1.00 for 10 consecutive days during extension, compliance will be confirmed.
- Failure to regain compliance by Nov 2, 2026 could result in delisting, with appeal rights.

## SEC filing metadata
- accession: 0001493152-26-021658
- form_type: 8-K
- ticker: CURX
- cik: 0002025942
- company_name: Curanex Pharmaceuticals Inc
- filed_at: 2026-05-07T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/2025942/000149315226021658/0001493152-26-021658-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/2025942/000149315226021658/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-26-021658
- JSON: https://secwatch.observer/filing/0001493152-26-021658.json
- Plain text: https://secwatch.observer/filing/0001493152-26-021658.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.